Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for hair loss are promising.

Estrogen therapy can reduce skin aging but has cancer risks.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Juniperus plants contain compounds with potential for developing various medical treatments.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Understanding breast cancer requires considering both medical advancements and social influences.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Wnt7a protein is crucial for development and tissue maintenance and plays varying roles in diseases and potential treatments.